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Sinonasal mucosal melanoma is a rare tumor that develops slowly and may manifest with non specific signs and 
symptoms, causing significant delay in diagnosis. Local recurrence is common and usually occurs within the first 
two years after the initial treatment. Prognosis of recurrent lesions is poor and 5-year survival ranges between 10-
47%. We report the clinical, radiographic, histopathological and immunohistochemical findings of a recurrent sino-
nasal mucosal melanoma which was diagnosed 10 years after the initial treatment, in a patient who presented with 
unilateral facial swelling and one-sided difficulty in breathing of two years duration. We discuss the causes of late 
diagnosis and review the negative predictive factors for recurrence and survival. As early diagnosis is of paramount 
importance for prognosis, we emphasize the signs and symptoms of patients with a history of sinonasal mucosal 
melanoma which should raise the suspicion for recurrence, in spite of a long time interval since diagnosis.




Sinonasal mucosal melanoma (SNMM) accounts 
for 0.3-2% of all primary malignant melanomas (1), 
approximately 2-9% of head and neck mucosal mela-
nomas (2) and 4-8% of all sinonasal malignancies (3). 
It affects patients in 5th to 8th decade of life (4-6), ge-
nerally older than those with cutaneous melanoma (1), 
probably because of an increase in the number of me-
lanocytes with advancing age (7). There is no definite 
gender predilection (1,4,8).
Most primary SNMMs (65.5-80.9%) arise within the 
nasal cavity (5,6), in particular in the nasal septum, the 
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inferior and middle turbinate, the lateral nasal wall and 
the nasal floor (3,4,6,8,9). The paranasal sinuses are 
less frequently involved, usually the maxillary sinuses 
(15.1-16.9%), followed by the ethmoid sinus, the frontal 
sinus and sphenoid sinus (5,6). The predominant mani-
festations of SNMMs are unilateral epistaxis and nasal 
obstruction (3,6,8,9). Symptoms vary according to tu-
mor size and location (8) and advanced cases may pre-
sent with enlargement causing nasal or facial deformity, 
facial pressure, pain, and less often frontal headache, 
hypoesthesia, unilateral hearing loss, rhinorrhea, hypos-
mia, congestion, breathing discomfort, diplopia, propto-
sis and epiphora (1,3,7-9). The indolent and non specific 
clinical appearance of SNMM may lead to a significant 
delay in diagnosis (1,8,9), which affects negatively the 
prognosis of the disease (9).
We present a recurrent mucosal melanoma diagnosed 
10 years after the initial diagnosis, with unilateral facial 
swelling and difficulty in breathing of two years dura-
tion, and discuss the causes of the delay in diagnosis. 
Prognostic factors affecting the recurrence and survival 
rate are also reviewed.
Case Report
A 65-year-old female was referred by her dentist for eva-
luation and management of right facial swelling, with a 
provisional diagnosis of a “maxillary cyst”. According 
to the patient, the swelling was initially noticed approxi-
mately 2 years before presentation, grew slowly and was 
associated with unilateral difficulty in breathing. Her 
medical history was significant for a primary mucosal 
melanoma of the right nasal turbinate treated 10 years 
ago with surgical excision without adjuvant radiothera-
py or chemotherapy. The patient did not attend a regular 
follow-up program. She did not take medications; she 
did not smoke and her recent complete blood count did 
not reveal any abnormality. 
Fig. 1: (a) Coronal Computer Tomography showed a solid, voluminous, hypointense lesion occupying 
the middle and inferior turbinate and the whole right sinus cavity, with thickening of the sinus mucosa 
and perforation of the sinus floor (red arrow) and the lateral nasal wall (yellow arrow). (b) A prominent 
expansion of the lateral nasal wall was observed on the magnetic resonance imaging (red arrows).
Intraoral examination was within normal limits. A coro-
nal Computer Tomography plane showed a solid, volu-
minous, hypointense lesion occupying the middle and 
inferior turbinate and the whole right sinus cavity, with 
thickening of the sinus mucosa and perforation of the 
sinus floor (red arrow) and the lateral nasal wall (yellow 
arrow) (Fig. 1a). A prominent expansion of the lateral na-
sal wall was observed on the magnetic resonance imaging 
(Fig. 1b, red arrows) and was considered consistent with 
the reported breathing discomfort. Extraoral clinical exa-
mination revealed a mild, diffuse swelling in the middle 
right side of face (Fig. 2a). With the provisional diagnosis 
of a recurrent melanoma, an incisional biopsy was per-
formed using a transoral approach (Fig. 2b) under local 
anesthesia. The surgical specimens were black in color 
(Fig. 2c) and measured 2x0.7x0.3cm in aggregate.
Histopathologic examination of 5μm thick formalin-
fixed and paraffin-embedded tissue sections stained 
with hematoxylin and eosin showed a tumor compo-
sed of spindle and epithelioid cells arranged in sheets 
or solid nests (Fig. 3a). Neoplastic cells exhibited large, 
pleomorphic, hyperchromatic or vesicular nuclei with 
multiple, prominent nucleoli and abundant eosinophi-
lic or hypochromatic cytoplasm with intracytoplasmic 
brown pigment aggregates that were consistent with me-
lanin (Fig. 3b). Approximately 10 mitotic figures were 
noted per high power field. Lymphocyte, plasma cells 
and polymorphonuclear neutrophil infiltrates, areas of 
hemorrhage and melanin granules were seen within the 
vascular stroma. Extensive tumor necrosis and foci of 
amorphous eosinophilic material were also observed. 
Tissue sections were treated with monoclonal antibodies 
against Melan-A/Mart-1 (clone A103, dilution 1:25, 
Dako, Glostrup, Denmark) and HMB-45 (clone MO643, 
dilution 1:50, Dako), using a standard streptavidin-bio-
tin-peroxidase system and the Dako EnvisionTM system 
(Dako). Α strong, diffuse positivity for Melan-A/Mart-1 
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Fig. 2: (a) Extraoral examination revealed a mild, diffuse swelling in the middle right side of face. (b) Incisional biopsy was performed 
under local anesthesia using a transoral approach and (c) revealed dark black colored surgical specimens.
Fig. 3: Histopathologic and immunohistochemical examination: (a) Spindle and epithelioid tumor cells, ar-
ranged in sheets or solid nests, (b) with large, pleomorphic, hyperchromatic/vesicular nuclei and abundant, 
eosinophilic/hypochromatic cytoplasm. Strong immunopositivity for (c) Melan-A/Mart-1 and (d) HMB-45 
[(a,b)hematoxylin-eosin stain; (c,d) streptavidin-biotin-peroxidase; original magnifications (a,c,d)x100, (b)
x400].
(Fig. 3c) and HMB-45 (Fig. 3d) was detected. Based 
on the histopathological and immunohistochemical fin-
dings, a diagnosis of a recurrent SNMM was rendered. 
The patient underwent a full course of chemotherapy, 
but she died of her disease 18 months later. At the time 
of biopsy, the patient gave informed consent for the fu-
ture use of her data for study.
Discussion
In the case presented herein the indolent growth of a 
recurrent SNMM caused significant delay in diagno-
sis. Primary SNMM develops slowly (9); its clinical 
features are non-specific and usually precede diagnosis 
up to 24 months (3,6). Growth of the recurrent lesion 
into the sinus cavity may have contributed to the non-
specific manifestations, such as facial swelling, which 
usually indicates a late stage of the disease (10). In a 
clinicopathological study of 44 SNMMs (3), outspread 
of the recurrent lesion to the paranasal sinuses was seen 
in 29.55%, and within the nasal cavity in 34.09%. Mu-
cosal melanomas of the sinus usually grow silently, be-
come evident at late stages (4,5) and bear a significantly 
poorer prognosis compared to the nasal mucosal mela-
nomas (3,4), due to delayed diagnosis and anatomical 
variations that complicate the surgical access (11). The 
unilateral difficulty in breathing probably results from 
nasal obstruction that is among the most frequent symp-
toms of SNMM (3,6,8,9) and is considered an unfavo-
rable prognostic factor when it is not associated with 
epistaxis (1). 
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In our case, diagnosis was also delayed by the underes-
timation of the patient’s history, possibly because of the 
long time interval between the initial diagnosis of the 
SNMM and its recurrence. Local recurrence is expected 
in 31%-85% of patients (4,9) and the average relapse time 
usually ranges from 9 to 25 months (3,4). However, recu-
rrence may occur even 10 years after the initial therapy, 
directly followed by multiple organ metastases and, as in 
our patient, a fatal outcome (1). The long-term interval 
from initial diagnosis until recurrence is more probable in 
SNMMs involving the paranasal sinuses (12).
Several clinical, i.e. advanced age at initial diagnosis, 
isolated obstructive phenomena and atypical manifesta-
tions, including headache, facial pain and maxillary ner-
ve anesthesia, anatomic, i.e. origin within the paranasal 
sinuses,  and histopathological parameters, such as the 
presence of ≥10 mitoses per high power field, increa-
sed level of melanotic pigmentation, pseudopapillary or 
sarcomatoid architecture, perineural or vasolymphatic 
invasion, undifferentiated cell morphology, multiple, 
satellite formation and a positive margin status at ini-
tial surgery, have been associated with an increased risk 
for locoregional recurrence or/and a poor survival in 
SNMM (1,3,4,6,12). In the current case, recurrence wi-
thin the sinus cavity (3,4), difficulty in breathing without 
epistaxis (1,3), and the advanced age of the patient (1,6), 
were negative prognostic factors.
Frequent and regular follow-up sessions for patients with 
a SNMM history, i.e. every 2-4 months, is recommended 
for at least the first decade post treatment (1), as early diag-
nosis and timely management of recurrences contribute 
to a longer survival (4). The five-year overall survival is 
poor and ranges between 10-47% (4, 5, 10), while 10-year 
survival decreases approximately at 20-25% (1,10). Clo-
se monitoring, early diagnosis of recurrence and prompt 
management is of outmost importance for prolonged sur-
vival (1,4,10). Surgical excision remains the treatment of 
choice, while radiotherapy, chemotherapy, biotherapy and 
molecular targeted may have a positive effect on recurren-
ce rate (12), without however increasing the overall survi-
val (3,13). Chemotherapy is suggested in advanced cases 
and in recurrent SNMMs (9) that are more infiltrative or 
multilocular compared to the primary tumor, and may 
pose difficulty for complete surgical resection (14).
In conclusion, the non-specific clinical manifestations, 
such as facial edema and breathing discomfort, in a pa-
tient with a history of SNMM should raise the suspicion 
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